| Leptin induces hippocampal synaptogenesis via CREB-regulated microRNA-132 suppression of p250GAP M Dhar, M Zhu, S Impey, TJ Lambert, T Bland, IN Karatsoreos, ... Molecular endocrinology 28 (7), 1073-1087, 2014 | 91 | 2014 |
| WLS-Wnt signaling promotes neuroendocrine prostate cancer T Bland, J Wang, L Yin, T Pu, J Li, J Gao, TP Lin, AC Gao, BJ Wu Iscience 24 (1), 2021 | 34 | 2021 |
| Leptin controls glutamatergic synaptogenesis and NMDA-receptor trafficking via Fyn kinase regulation of NR2B T Bland, M Zhu, C Dillon, GS Sahin, JL Rodriguez-Llamas, SM Appleyard, ... Endocrinology 161 (2), bqz030, 2020 | 27 | 2020 |
| USP8 deubiquitinates the leptin receptor and is necessary for leptin-mediated synapse formation T Bland, GS Sahin, M Zhu, C Dillon, S Impey, SM Appleyard, GA Wayman Endocrinology 160 (8), 1982-1998, 2019 | 24 | 2019 |
| Branched dimerization of Tat peptide improves permeability to HeLa and hippocampal neuronal cells I AbrreyáMonreal Chemical communications 51 (25), 5463-5466, 2015 | 24 | 2015 |
| Tropomodulin isoforms utilize specific binding functions to modulate dendrite development KT Gray, AK Suchowerska, T Bland, M Colpan, G Wayman, T Fath, ... Cytoskeleton 73 (6), 316-328, 2016 | 22 | 2016 |
| WLS-Wnt signaling promotes neuroendocrine prostate cancer. iScience 24 T Bland, J Wang, L Yin, T Pu, J Li, J Gao, TP Lin, AC Gao, BJ Wu | 5 | 2021 |
| Repurposing antimuscarinics to treat lethal chemoresistant prostate and lung cancers. TB Bland, B Wu Journal of Clinical Oncology 38 (15_suppl), e15636-e15636, 2020 | 3 | 2020 |
| Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer J Wang, J Wei, T Pu, A Zeng, V Karthikeyan, B Bechtold, K Vo, J Chen, ... Cell Reports Medicine 5 (2), 2024 | 1 | 2024 |
| Multimedia design for learner interest and achievement: a visual guide to pharmacology T Bland, M Guo, TA Dousay BMC Medical Education 24 (1), 113, 2024 | | 2024 |
| ClinLearning: An Online Clinical Tutoring and Crowdsourced Treatment Recommendation System HM Jamil, T Bland, E Bernitsas, N Carr, D Phillips, F Shawon, B Seyoum, ... International Conference on Information Integration and Web Intelligence …, 2023 | | 2023 |
| Chemoresistant non-small cell lung cancer: A resensitizing strategy utilizing antimuscarinics T Bland, E Overfelt Cancer Research 83 (7_Supplement), 1744-1744, 2023 | | 2023 |
| Combination therapy to treat cancer and uses thereof WU Boyang, B Bechtold, VO Karen, T Bland US Patent App. 17/599,618, 2022 | | 2022 |
| Repurposing an overactive bladder drug to treat chemoresistant lung cancer J Bassett, T Bland Cancer Research 82 (12_Supplement), 1090-1090, 2022 | | 2022 |
| Inhibition of CHRM1 reverts docetaxel resistance in castration‐resistant prostate cancer J Wang, T Bland, J Wei, T Pu, TP Lin, B Wu The FASEB Journal 36, 2022 | | 2022 |
| REGULATION OF CHEMORESISTANCE BY CHRM1 IN NON-SMALL CELL LUNG CANCER S Simpson, T Bland JOURNAL OF INVESTIGATIVE MEDICINE 70 (1), 164-165, 2022 | | 2022 |
| Repurposing Neuroactive Drugs in Oncology: A Mini-Review T Bland, B Wu Modern Approaches in Drug Designing 2 (5), 2020 | | 2020 |
| WLS-WNT SIGNALING PROMOTES ENZALUTAMIDE-RESISTANT NEUROENDOCRINE PROSTATE CANCER T Bland 2020 Annual Meeting, 2020 | | 2020 |
| CHRM1-mediated acetylcholine signaling protects prostate cancer cells from the chemotherapy agent docetaxel T Bland, K Vo, B Bechtold, B Wu Cancer Research 79 (13), 2019 | | 2019 |
| Neurotrophic Actions of Leptin in the Developing Hippocampus T Bland Washington State University, 2017 | | 2017 |
